Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer
NCT00920192
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma, Hepatocellular
Interventions
DRUG:
Foretinib
Sponsor
GlaxoSmithKline